Literature DB >> 11391240

Late onset of severe graft-versus-host disease in a pediatric liver transplant recipient.

S P Dunn1, L J Krueger, L Butani, H Punnett.   

Abstract

We report the management of a patient with the late onset of chronic graft-versus-host disease (GVHD) after orthotopic liver transplantation. GVHD is a rare complication of solid organ transplants that usually presents early after transplantation and is fatal in the majority of cases. Our patient differs from the typical patient with GVHD in that the onset of her disease was very late. Although most treatment to date consisted of an increase in immunosuppressive therapy, our patient showed an excellent response to a reduction. This resulted in the abatement of the symptoms of GVHD and the preservation of her allograft function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391240     DOI: 10.1097/00007890-200105270-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Harnessing Expressed Single Nucleotide Variation and Single Cell RNA Sequencing To Define Immune Cell Chimerism in the Rejecting Kidney Transplant.

Authors:  Andrew F Malone; Haojia Wu; Catrina Fronick; Robert Fulton; Joseph P Gaut; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

2.  Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation.

Authors:  Xiao-Bo Chen; Jie Yang; Ming-Qing Xu; Tian-Fu Wen; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 3.  Graft-versus-host disease after liver transplantation: a comprehensive literature review.

Authors:  Sami Akbulut; Mehmet Yilmaz; Sezai Yilmaz
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 4.  Immunological basis for treatment of graft versus host disease after liver transplant.

Authors:  Vikrant Rai; Nicholas Edward Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-02-24       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.